Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Sun Pharma, Lupin, Dr Reddy's Labs on declines: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Lupin and Dr Reddy's Laboratories on declines.

    • Gautam Chhaochharia overweight on pharma space

      Gautam Chhaochharia, Head-India Research at UBS is overweight on pharma space.

    • Buy LIC Housing 520 Call, ONGC 220 Put: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying LIC Housing Finance 520 Call and ONGC 220 Put.

    • Buy Pidilite, Oriental Bank; sell Union Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Pidilite Industries and Oriental Bank of Commerce and sell Union Bank of India.

    • Hold Sun Pharmaceutical Industries: AK Prabhakar

      AK Prabhakar of IDBI Capital suggests holding Sun Pharmaceutical Industries.

    • See upmove in Sun Pharma; like BEML, Coal India: Prakash Gaba

      Prakash Gaba of prakashgaba.com expects good upmove in Sun Pharma with a target of Rs 790 and likes BEML and Coal India.

    • Pharma space looks attractive: Parag Thakkar

      Parag Thakkar of HDFC Securities is of the view that pharma space looks attractive.

    • Buy REC, Reliance Industries, Voltas, Sun Pharma: Rahul Shah

      Rahul Shah of Motilal Oswal is of the view that one can buy Rural Electrification Corporation, Reliance Industries, Voltas and Sun Pharma.

    • Strides Shasun may test Rs 1350-1400: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that Strides Shasun may test Rs 1350-1400.

    • Here are a few investment ideas from Daljeet Singh Kohli

      In an interview to CNBC-TV18, Daljeet Singh Kohli of India Nivesh Securites shared his readings and outlook on specific stocks and sector.

    • Prefer Dr Reddy's, Sun Pharma, SBI, HDFC Bank, HDFC: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may see momentum is stocks like Dr Reddy's Laboratories, Sun Pharmaceutical Industries, State Bank of India, HDFC Bank and HDFC.

    • Buy Sun Pharma, Idea Cellular; sell Hindalco: Aditya Agarwal

      Aditya Agarwal, Senior Derivative Analyst at Way2wealth Securities is of the view that one can buy Sun Pharma, Idea Cellular and NCC and sell Hindalco Industries.

    • Ashok Leyland may test Rs 102, Sun Pharma Rs 805: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Ashok Leyland may test Rs 102 while Sun Pharma may hit Rs 805 and Jain Irrigation may head to Rs 80.

    • Buy Dena Bank, SREI Infra, Biocon, Sun Pharma Adv: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Dena Bank, SREI Infra, Kesoram Industries, Biocon and Sun Pharma Advanced Research Company.

    • Best buys: Which stocks are brokerages backing after Brexit

      On Friday, the day of Brexit referendum results, the benchmark Sensex lost nearly 1,100 points intra-day before closing 604.51 points lower. Investors' wealth in stock market took a hit of nearly Rs 1.8 lakh crore on that day.

    • Brexit impact limited on pharma, US biz to offset risk: Analysts

      Brokerage houses do not see any major impact of Brexit on pharma companies' earnings. In fact they have not changed their views post Friday's event, saying companies may get impacted only by currency volatility globally. According to them, any EU impact will offset by US large exposure to the US.

    • SP Tulsian says pharma is theme for July series, go long in them

      I won‘t be surprised to see pharma as the story for July series and won‘t be surprised in seeing a big upsurge in all big pharma, said SP Tulsian.

    • Buy Sun Pharma, BPCL, HPCL; sell UPL, Bata: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharmaceutical Industries, Bharat Petroleum Corporation and Hindustan Petroleum Corporation and advises selling UPL and Bata India.

    • Stay invested in Sun Pharma: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, one may stay invested in Sun Pharmaceutical Industries.

    • Sell TCS; buy YES Bank, Sun Pharmaceutical: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Tata Consultancy Services and advises buying YES Bank and Sun Pharmaceutical Industries.

    • Buy Lupin for long term, says Parag Thakkar

      Parag Thakkar of HDFC Securities is of the view that one can buy Lupin for long term.

    • Buy Sun Pharma; Sobha may test Rs 450: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharmaceutical Industries for long term and feels that Sobha may test Rs 450 while Coal India may hit Rs 400.

    • Pharma good contra buy: Phani Sekhar

      P Phani Sekhar of Karvy Stock Broking is of the view that pharma is a good contra buy.

    • Buy Sun Pharma, JSW Steel; sell Tata Motors: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma and JSW Steel and advises selling Tata Motors.

    • Sun Pharma may test Rs 825-835, says Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas feels that Sun Pharma may test Rs 825-835.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347